miRNA-375 Combined EB-DNA as Differential Diagnostic Biomarker for EBV-IM and EBV-HLH in Children
Preprint
- 11 June 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
In children, Epstein-Barr Virus (EBV) often causes infectious mononucleosis (EBV-IM) but can escalate to a severe condition called EBV-associated hemophagocytic lymphohistiocytosis (EBV-HLH). Differentiating these conditions is vital for proper treatment and prognosis. This study aimed to find plasma biomarkers to distinguish between EBV-IM and EBV-HLH. A retrospective analysis was performed on 17 children with EBV-IM and 23 with EBV-HLH. Selected microRNAs (miRNAs) were measured in plasma using qPCR, and EBV DNA was isolated and quantified. Biomarker effectiveness was assessed using constructing receiver operating characteristic (ROC) curves and the area under the curve (AUC) calculations. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis revealed a significant enrichment of miR-375, miR-148a-3p, and miR-92a-1-5p within the Viral Carcinogenesis pathway. Quantitative PCR validation demonstrated a marked upregulation of miR-375 and miR-148a-3p in patients with EBV-HLH compared to those with EBV-IM, whereas the expression of miR-92a-1-5p did not show a statistically significant difference between the groups. Notably, receiver operating characteristic (ROC) analysis indicated that the combined evaluation of miR-375 and EBV-DNA load achieved superior diagnostic discrimination between EBV-HLH and EBV-IM, with an AUC of 0.951, highlighting its potential high clinical utility. The integrated biomarker panel, consisting of miR-375 and EBV-DNA load, demonstrated high diagnostic accuracy in distinguishing between EBV-HLH and EBV-IM. These findings offer a clinically applicable tool for precise differential diagnosis and therapeutic stratification.Keywords
All Related Versions
This publication has 26 references indexed in Scilit:
- Emerging drugs for Epstein-Barr virus associated-diseasesEuropean Journal of Medicinal Chemistry, 2025
- The ability of CD4dimCD8+ T cells to distinguish between Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis and pediatric infectious mononucleosisImmunologic Research, 2025
- Novel plasma microRNA expression features in diagnostic use for Epstein-Barr virus-associated febrile diseasesHeliyon, 2024
- Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosisCell, 2023
- Epstein-Barr virus: Biology and clinical diseaseCell, 2022
- Analysis of two laboratory tests for determination of EBV‐IM in childrenJournal of Medical Virology, 2021
- Exosomes derived from osteogenic tumor activate osteoclast differentiation and concurrently inhibit osteogenesis by transferring COL1A1‐targeting miRNA‐92a‐1‐5pJournal of Extracellular Vesicles, 2021
- Clinical application of Epstein-Barr virus DNA loads in Epstein-Barr virus-associated diseases: A cohort studyJournal of Infection, 2021
- Diagnostic Evaluation of Mononucleosis-Like IllnessesThe American Journal of Medicine, 2007
- HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosisPediatric Blood & Cancer, 2006